Elevance Health (ELV) 재무상태표
NYSE · Healthcare · Medical - Healthcare Plans · 직원 96,615명 · CEO Gail Koziara Boudreaux
- 주가
- $420.07 -0.46%
- 시가총액
- $911억
- 기업가치
- $1120억
- 최근 실적
- Q3 '26 2026-10-21 제출
- 다음 실적
- 2027-01-27 EPS 추정 $2.08
Elevance Health (ELV)의 Q3 '26말 현금 및 단기투자는 $378억, 리스 포함 차입금은 $308억입니다. 자산총계 $1280억, 부채총계 $830억, 주주지분 $447억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $65.3억 | $62.3억 | $65억 | $78.7억 | $82.9억 | $75억 | $85.6억 | $87.1억 | $94.9억 | $96.6억 | $102억 | $103억 | |
| 단기투자 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $259억 | $273억 | $275억 | |
| 매출채권 | $125억 | $132억 | $133억 | $123억 | $131억 | $156억 | $159억 | $147억 | $152억 | $228억 | $234억 | $246억 | |
| 기타 유동자산 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $86.8억 | $62.8억 | $61.1억 | |
| 유동자산 | $190억 | $194억 | $198억 | $202억 | $213억 | $231억 | $245억 | $234억 | $247억 | $670억 | $672억 | $685억 | |
| 유형자산(순액) | $49.4억 | $44.5억 | $44.5억 | $45.1억 | $52.2억 | $46.2억 | $46.4억 | $46.6억 | $51.3억 | $46.6억 | $46.5억 | $46.1억 | |
| 장기투자 | $368억 | $376억 | $372억 | $404억 | $372억 | $374억 | $378억 | $393억 | $386억 | $121억 | $124억 | $127억 | |
| 영업권 | $253억 | $259억 | $260억 | $260억 | $283억 | $284억 | $284억 | $285억 | $283억 | $283억 | $283억 | $283억 | |
| 무형자산 | $103억 | $107억 | $104억 | $103억 | $121억 | $119억 | $115억 | $113억 | $112억 | $111억 | $110억 | $109억 | |
| 이연법인세자산 | $2.28억 | $0 | $0 | $0 | $2.06억 | $0 | $0 | $0 | $2.98억 | $0 | $0 | $0 | |
| 기타 비유동자산 | $124억 | $138억 | $151억 | $152억 | $126억 | $143억 | $152억 | $157억 | $132억 | $25.8억 | $29억 | $27.3억 | |
| 비유동자산 | $899억 | $925억 | $932억 | $963억 | $955억 | $966억 | $975억 | $994억 | $968억 | $588억 | $593억 | $593억 | |
| 자산총계 | $1090억 | $1120억 | $1130억 | $1170억 | $1170억 | $1200억 | $1220억 | $1230억 | $1210억 | $1260억 | $1260억 | $1280억 | |
| 부채 | |||||||||||||
| 매입채무 | $161억 | $165억 | $152억 | $153억 | $157억 | $168억 | $172억 | $171억 | $171억 | $62.1억 | $251억 | $83.2억 | |
| 단기차입금 | $20.4억 | $44.8억 | $31.3억 | $24.6억 | $21.7억 | $18.9억 | $20.1억 | $9.29억 | $13.8억 | $7.24억 | $3.75억 | $3.75억 | |
| 이연수익 | $14억 | $14.7억 | $14.8억 | $17.9억 | $15.1억 | $16.4억 | $15.6억 | $0 | $14.9억 | $17.6억 | $16.4억 | $16.4억 | |
| 기타 유동부채 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $366억 | $56.7억 | $363억 | |
| 유동부채 | $196억 | $224억 | $198억 | $196억 | $194억 | $203억 | $207억 | $181억 | $200억 | $453억 | $328억 | $467억 | |
| 장기차입금 | $239억 | $220억 | $246억 | $247억 | $299억 | $281억 | $282억 | $312억 | $313억 | $311억 | $307억 | $304억 | |
| 리스부채(비유동) | $6.85억 | $0 | $0 | $0 | $6.58억 | $0 | $0 | $0 | $5.29억 | $0 | $0 | $0 | |
| 이연수익(비유동) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $18.3억 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $19.7억 | $22억 | $20.4억 | $20.9억 | $21.5억 | $21.2억 | $20.1억 | $23.2억 | $21.1억 | $17.9억 | $22.1억 | $14.9억 | |
| 기타 비유동부채 | $234억 | $246억 | $243억 | $263억 | $234억 | $265억 | $272억 | $253억 | $235억 | $35.7억 | $158억 | $44.8억 | |
| 비유동부채 | $500억 | $488억 | $509억 | $531억 | $560억 | $568억 | $574억 | $606억 | $575억 | $365억 | $486억 | $363억 | |
| 부채총계 | $695억 | $712억 | $707억 | $727억 | $755억 | $771억 | $781억 | $787억 | $775억 | $818억 | $814억 | $830억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | $200만 | |
| 이익잉여금 | $317억 | $331억 | $346억 | $352억 | $335억 | $345억 | $355억 | $356억 | $354억 | $358억 | $367억 | $374억 | |
| 기타포괄손익누계액 | -$13.1억 | -$13.7억 | -$13.9억 | -$4.89억 | -$11.5억 | -$9.11억 | -$7.6억 | -$5.43억 | -$4.51억 | -$7.41억 | -$7.11억 | -$16.8억 | |
| 주주지분 | $393억 | $406억 | $422억 | $438억 | $413억 | $425억 | $437억 | $440억 | $439억 | $439억 | $449억 | $447억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $267억 | $265억 | $277억 | $271억 | $327억 | $300억 | $302억 | $321억 | $332억 | $318억 | $310억 | $308억 | |
| 순차입금(차입금 - 현금) | $201억 | $202억 | $212억 | $193억 | $244억 | $225억 | $216억 | $234억 | $237억 | $222억 | $208억 | $204억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $40.8억 | $36.1억 | $39.3억 | $49.4억 | $57.4억 | $48.8억 | $73.9억 | $65.3억 | $82.9억 | $94.9억 | |
| 매출채권 | $58.6억 | $61.8억 | $67.4억 | $75.8억 | $81.3억 | $96.9억 | $117억 | $125억 | $131억 | $152억 | |
| 유동자산 | $99.4억 | $97.9억 | $107억 | $125억 | $139억 | $146억 | $191억 | $190억 | $213억 | $247억 | |
| 유형자산(순액) | $19.8억 | $21.7억 | $27.4억 | $37.1억 | $41.3억 | $45.5억 | $49.2억 | $49.4억 | $52.2억 | $51.3억 | |
| 장기투자 | $214억 | $249억 | $225억 | $255억 | $298억 | $340억 | $333억 | $368억 | $372억 | $386억 | |
| 영업권 | $176억 | $192억 | $205억 | $205억 | $217억 | $242억 | $244억 | $253억 | $283억 | $283억 | |
| 무형자산 | $79.6억 | $83.7억 | $90.1억 | $86.7억 | $94.1억 | $106억 | $103억 | $103억 | $121억 | $112억 | |
| 이연법인세자산 | $13억 | $9.2억 | $8.99억 | $8.01억 | $16.6억 | $1.03억 | $1.37억 | $2.28억 | $2.06억 | $2.98억 | |
| 기타 비유동자산 | $62억 | $60.4억 | $62억 | $65.9억 | $76.8억 | $93.9억 | $105억 | $124억 | $126억 | $132억 | |
| 비유동자산 | $565억 | $617억 | $618억 | $657억 | $744억 | $829억 | $836억 | $899억 | $955억 | $968억 | |
| 자산총계 | $664억 | $715억 | $725억 | $783억 | $883억 | $975억 | $1030억 | $1090억 | $1170억 | $1210억 | |
| 부채 | |||||||||||
| 매입채무 | $78.9억 | $79.9억 | $74.5억 | $88.4억 | $114억 | $135억 | $156억 | $161억 | $157억 | $171억 | |
| 단기차입금 | $13.7억 | $25.5억 | $19.9억 | $24.6억 | $8.1억 | $20.1억 | $19.5억 | $20.4억 | $21.7억 | $13.8억 | |
| 이연수익 | $0 | $0 | $0 | $0 | $0 | $0 | $11.1억 | $14억 | $15.1억 | $14.9억 | |
| 유동부채 | $92.6억 | $105억 | $94.5억 | $113억 | $122억 | $155억 | $187억 | $196억 | $194억 | $200억 | |
| 장기차입금 | $144억 | $174억 | $172억 | $183억 | $202억 | $220억 | $231억 | $239억 | $299억 | $313억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $4.82억 | $8.47억 | $8.64억 | $7.51억 | $6.85억 | $6.58억 | $5.29억 | |
| 이연수익(비유동) | $9.72억 | $8.6억 | $9.02억 | $10.2억 | $12.6억 | $11.5억 | $11.1억 | $0 | $0 | $0 | |
| 이연법인세부채 | $40.8억 | $26.5억 | $28.6억 | $30.3억 | $36.8억 | $28.1억 | $20.2억 | $19.7억 | $21.5억 | $21.1억 | |
| 기타 비유동부채 | $126억 | $135억 | $135억 | $124억 | $169억 | $190억 | $208억 | $234억 | $234억 | $235억 | |
| 비유동부채 | $320억 | $344억 | $345억 | $352억 | $429억 | $458억 | $478억 | $500억 | $560억 | $575억 | |
| 부채총계 | $413억 | $450억 | $439억 | $465억 | $551억 | $613억 | $664억 | $695억 | $755억 | $775억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $260만 | $260만 | $300만 | $300만 | $300만 | $200만 | $200만 | $200만 | $200만 | $200만 | |
| 이익잉여금 | $166억 | $181억 | $200억 | $226억 | $238억 | $271억 | $296억 | $317억 | $335억 | $354억 | |
| 기타포괄손익누계액 | -$2.68억 | -$1.02억 | -$9.86억 | -$2.96억 | $1.5억 | -$1.78억 | -$24.9억 | -$13.1억 | -$11.5억 | -$4.51억 | |
| 주주지분 | $251억 | $265억 | $285억 | $317억 | $332억 | $361억 | $362억 | $393억 | $413억 | $439억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $157억 | $199억 | $192억 | $212억 | $218억 | $249억 | $258억 | $267억 | $327억 | $332억 | |
| 순차입금(차입금 - 현금) | $117억 | $163억 | $153억 | $163억 | $161억 | $200억 | $184억 | $201억 | $244억 | $237억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
데이터 기준일 2026-11-01